Education
About Us
Working with TipRanks
Follow Us
Zim Laboratories Ltd. (IN:ZIMLAB)
:ZIMLAB
ZIMLAB Stock Chart & Stats
₹71.04
-₹1.76(-1.66%)
At close: 4:00 PM EST
₹71.04
-₹1.76(-1.66%)
Day’s Range― - ―
52-Week Range₹65.00 - ₹126.95
Previous CloseN/A
Volume52.11K
Average Volume (3M)6.28K
Market Cap
₹3.49B
Enterprise Value₹4.65B
Total Cash (Recent Filing)₹20.37M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)52.6
Beta1.02
Next Earnings
Feb 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding48,735,813
10 Day Avg. Volume5,950
30 Day Avg. Volume6,279
Financial Highlights & Ratios
PEG Ratio-1.14
Price to Book (P/B)1.62
Price to Sales (P/S)1.09
P/FCF Ratio1.15K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zim Laboratories Ltd. News
ZIMLAB FAQ
What was Zim Laboratories Ltd.’s price range in the past 12 months?
Zim Laboratories Ltd. lowest stock price was ₹65.00 and its highest was ₹126.95 in the past 12 months.
What is Zim Laboratories Ltd.’s market cap?
Zim Laboratories Ltd.’s market cap is ₹3.49B.
When is Zim Laboratories Ltd.’s upcoming earnings report date?
Zim Laboratories Ltd.’s upcoming earnings report date is Feb 02, 2026 which is in 45 days.
How were Zim Laboratories Ltd.’s earnings last quarter?
Zim Laboratories Ltd. released its earnings results on Nov 12, 2025. The company reported -₹0.087 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.087.
Is Zim Laboratories Ltd. overvalued?
According to Wall Street analysts Zim Laboratories Ltd.’s price is currently Overvalued.
Does Zim Laboratories Ltd. pay dividends?
Zim Laboratories Ltd. pays a Annually dividend of ₹0.167 which represents an annual dividend yield of N/A. See more information on Zim Laboratories Ltd. dividends here
What is Zim Laboratories Ltd.’s EPS estimate?
Zim Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zim Laboratories Ltd. have?
Zim Laboratories Ltd. has 48,735,813 shares outstanding.
What happened to Zim Laboratories Ltd.’s price movement after its last earnings report?
Zim Laboratories Ltd. reported an EPS of -₹0.087 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.928%.
Which hedge fund is a major shareholder of Zim Laboratories Ltd.?
Currently, no hedge funds are holding shares in IN:ZIMLAB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zim Laboratories Ltd.
Zim Laboratories Ltd. (ZIMLAB) is a pharmaceutical company based in India, primarily engaged in the development, manufacturing, and marketing of a diverse range of products including formulations, active pharmaceutical ingredients (APIs), and custom manufacturing services. The company operates in various therapeutic segments such as anti-infectives, pain management, and cardiovascular health, catering to both domestic and international markets. ZIMLAB emphasizes research and development to innovate and expand its product portfolio, ensuring compliance with global quality standards.
Technical Analysis
Albert David Ltd
―
Lyka Labs Limited
―
Medicamen Biotech Limited
―
Nectar Lifesciences Ltd.
―
Venus Remedies Limited
―